Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism.
about
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterationsComputational modeling of cardiac fibroblasts and fibrosisThe non-palindromic adaptor-PCR method for the identification of the T-cell receptor genes of an interferon-gamma-secreting T-cell hybridomaspecific for trans-sialidase, an immunodominant Trypanosoma cruzi antigen.Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity.Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.Innate and acquired immunity in the pathogenesis of Chagas disease.Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry.Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.Autonomic neuroimmunomodulation in chagasic cardiomyopathy.Control of inflammatory heart disease by CD4+ T cells.Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune responseImmunoregulatory actions of melatonin and zinc during chronic Trypanosoma cruzi infection.Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.Cardiac damage induced by immunization with heat-killed Trypanosoma cruzi is not antibody mediated.Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.Vaccine-linked chemotherapy improves benznidazole efficacy for acute Chagas disease.Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.Genetic susceptibility to Chagas disease: an overview about the infection and about the association between disease and the immune response genes.BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity.Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy.
P2860
Q24520510-D5919CDD-3964-49BC-AB1F-331DBC18CE70Q30278019-D7E5F208-3D7E-48A9-A3FB-B628A27A69E6Q33234761-F7F95A37-4B1C-4346-9C10-2A975077660CQ33267316-6FCC85B2-CCF2-414F-B9B7-EC4B98AD962BQ34194841-22182C6B-E38F-41A9-8132-74B610D763A2Q35009081-0EB54ACC-12D8-4A62-9D0C-38C4CF62A40EQ35085050-902FECB1-7032-4810-99CE-836800B08F2BQ35750253-2E114AEB-06D5-46F2-8B74-B68D7293B8BFQ35994773-4AA2457C-C3A6-4BF2-A5D5-948C7006C392Q36385476-94EC8D27-AEF7-4893-BC18-77014EE2CB42Q36933422-685CF29D-7F73-4444-8022-7D34BF9E8220Q37961913-A73DC1F1-C032-4BEC-B31B-2958DBDDAF19Q38009776-1395E55A-5B77-4C8E-8F56-7A5F89979C55Q38108397-8DF67449-0545-4F9E-900A-E56DEB4A3B25Q39730057-0152B28D-1A58-4776-B98F-FB03FF8182C0Q41528104-636EA183-D8EE-401E-BDF1-FF3457606EAFQ41552272-943D60B8-A516-4716-8DA0-01B86899A05CQ44113294-07083D44-0935-4169-BF84-1FCA690C4637Q45956815-4A5671E2-1C8D-4832-87BC-23002E0E4D6EQ47557112-3E263451-CC32-48CB-9297-0333A8A2BD87Q51745401-F378C080-C7F8-41E7-B8C5-400B8B905597Q53792154-60B38804-5465-4779-B3D0-474FA448FA18Q54234613-EA6F7FD7-1D43-4709-9821-AE0298BDA3F9Q55709087-C6FEC085-B434-458B-81CB-A090C5489B74
P2860
Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Modulation of chagasic cardiom ...... mmation and tissue parasitism.
@ast
Modulation of chagasic cardiom ...... mmation and tissue parasitism.
@en
type
label
Modulation of chagasic cardiom ...... mmation and tissue parasitism.
@ast
Modulation of chagasic cardiom ...... mmation and tissue parasitism.
@en
prefLabel
Modulation of chagasic cardiom ...... mmation and tissue parasitism.
@ast
Modulation of chagasic cardiom ...... mmation and tissue parasitism.
@en
P2093
P2860
P1476
Modulation of chagasic cardiom ...... mmation and tissue parasitism.
@en
P2093
Bellintani MC
Pontes-de-Carvalho L
Ribeiro-dos-Santos R
Silva-Mota KN
P2860
P304
P356
10.1016/S0002-9440(10)61741-5
P407
P577
2001-08-01T00:00:00Z